TuHURA Biosciences (HURA) Non Operating Income (2012 - 2024)
TuHURA Biosciences' (HURA) quarterly Non Operating Income came in at $48000.0 in Q3 2024, down 35.14% quarter-over-quarter from $74000.0 in Q1 2024.
TuHURA Biosciences (HURA) Non Operating Income (2012 - 2024) Analysis & Trends
TuHURA Biosciences' Non Operating Income history runs 13 years deep, the most recent figure standing at $48000.0 for Q3 2024.
- On a quarterly basis, Non Operating Income changed N/A year-over-year to $48000.0 in Q3 2024; TTM through Sep 2024 was $118000.0, a 11.28% decrease from a year earlier, with the FY2024 full-year figure at $131000.0, down 10.88% from the prior year.
- Non Operating Income fell to $48000.0 in Q3 2024 per HURA's latest filing, from $74000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $74000.0 in Q1 2024 and bottomed at -$35000.0 in Q4 2020.
- The 5-year median for Non Operating Income is $3500.0 (2021), against an average of $9750.0.
- Across the five-year window, Non Operating Income sank 1650.0% in 2021 and surged 2150.0% in 2022, its largest moves.
- Year by year, Non Operating Income stood at -$35000.0 in 2020, then soared by 105.71% to $2000.0 in 2021, then jumped by 2150.0% to $45000.0 in 2022, then tumbled by 108.89% to -$4000.0 in 2023, then soared by 1300.0% to $48000.0 in 2024.
- Per Business Quant, the three latest HURA Non Operating Income figures stand at $48000.0 (Q3 2024), $74000.0 (Q1 2024), and -$4000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -8.59 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 48,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 45,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -35,000.00 |
| Mar 31, 2021 | -30,000.00 |
| Dec 31, 2020 | -35,000.00 |
| Sep 30, 2020 | -33,000.00 |
| Jun 30, 2020 | -2,000.00 |
| Mar 31, 2020 | 19,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 316,664.00 |
| Mar 31, 2019 | 7,389.00 |